Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Obesity in an ageing population 'is biggest issue for the ... a new class of drug which mimics the action of GLP-1 - a naturally occurring gut hormone which is released after eating. Their effect is ...

Metabolic diseases, such as cardiovascular diseases and type 2 diabetes, have become one of the world’s largest public health ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

According to Dr Rakesh Kumar Prasad, Consultant in Diabetology and Endocrinology at Fortis Hospital, Noida, while not ...

New therapies for atherosclerosis, obesity and type 2 diabetes are needed. Thyroid hormone excess has potentially useful effects, including lowering of serum cholesterol and reduction of body fat ...

Novo Nordisk's experimental obesity drug CagriSema shows similar side effects to its GLP-1 drugs, with potential for 25% ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, ...

The hormones in our gut may play a significant role in the aging process. A study has found that gut hormones could control ...

“Among people with overweight or obesity, one in three live with MASH ... These medications act on gut hormones and are proven to have powerful effects on weight loss, heart health and other ...